Actively Recruiting
Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine
Led by University of Colorado, Denver · Updated on 2024-10-01
100
Participants Needed
1
Research Sites
277 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day readmissions
CONDITIONS
Official Title
Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female
- Age 18 years or older
- Diagnosis of lumbar stenosis
You will not qualify if you...
- Co-morbidities that prevent surgery
- Under 18 years of age
- Pregnant
- Breastfeeding
- Need for instrumented fusion
- Prisoners
- Intra-operative cerebrospinal fluid leak detected during surgery
- Daily pre-operative opioid use exceeding 25 morphine equivalents per day
- Previous lumbar surgery at the indicated level
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States, 80045
Actively Recruiting
Research Team
J
Jens-Peter Witt, MD, PhD
CONTACT
A
Akal Sethi, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here